Mustang Historical Cash Flow
| MBIO Stock | USD 0.22 0.01 4.76% |
Analysis of Mustang Bio cash flow over time is an excellent tool to project Mustang Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 124.5 K or Other Cashflows From Investing Activities of 7.2 M as it is a great indicator of Mustang Bio ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Mustang Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mustang Bio is a good buy for the upcoming year.
Mustang |
About Mustang Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Mustang balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Mustang's non-liquid assets can be easily converted into cash.
Mustang Bio Cash Flow Chart
Add Fundamental
Investments
Securities or assets acquired for generating income or appreciating in value, not used in daily operations.Capital Expenditures
Capital Expenditures are funds used by Mustang Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Mustang Bio operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Mustang Bio financial statement analysis. It represents the amount of money remaining after all of Mustang Bio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Mustang Bio's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Mustang Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.At this time, Mustang Bio's Investments are very stable compared to the past year. As of the 5th of January 2025, Other Cashflows From Investing Activities is likely to grow to about 7.2 M, while Sale Purchase Of Stock is likely to drop about 789.2 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Capital Expenditures | 3.1M | 114K | 131.1K | 124.5K | Depreciation | 3.0M | 2.2M | 2.6M | 1.4M |
Mustang Bio cash flow statement Correlations
Click cells to compare fundamentals
Mustang Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Mustang Bio cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 181K | 29.5M | 35.2M | 923K | 830.7K | 789.2K | |
| Investments | (4.4M) | (5.4M) | (3.0M) | 5.5M | 6.3M | 6.6M | |
| Change In Cash | 36.4M | 11.8M | (34.0M) | (69.7M) | (62.7M) | (59.6M) | |
| Total Cashflows From Investing Activities | 557K | 13.9M | (4.4M) | (5.4M) | (6.2M) | (6.5M) | |
| Other Cashflows From Financing Activities | (3.2M) | (1.1M) | (2.6M) | (267K) | (307.1K) | (322.4K) | |
| Depreciation | 1.8M | 2.3M | 3.0M | 2.2M | 2.6M | 1.4M | |
| Capital Expenditures | 4.4M | 5.4M | 3.1M | 114K | 131.1K | 124.5K | |
| Total Cash From Operating Activities | (37.3M) | (53.7M) | (65.1M) | (49.5M) | (44.5M) | (46.8M) | |
| Change To Operating Activities | (2K) | (145K) | (62K) | (464K) | (417.6K) | (396.7K) | |
| Net Income | (60.0M) | (66.4M) | (77.5M) | (51.6M) | (46.4M) | (48.8M) | |
| Total Cash From Financing Activities | 78.1M | 70.8M | 34.1M | (26.1M) | (30.0M) | (28.5M) | |
| Other Cashflows From Investing Activities | (2.5M) | (1.4M) | (238K) | 6M | 6.9M | 7.2M | |
| Change To Netincome | 5.0M | 2.7M | 15.5M | 11.0M | 12.7M | 9.7M | |
| Change To Liabilities | 2.6M | 360K | 3.2M | (138K) | (158.7K) | (150.8K) | |
| Free Cash Flow | (41.7M) | (59.0M) | (68.1M) | (49.6M) | (44.6M) | (46.9M) | |
| Change In Working Capital | 3.1M | (637K) | 4.0M | (3.0M) | (2.7M) | (2.5M) | |
| Other Non Cash Items | 14.8M | 7.7M | 3.1M | 2.3M | 2.1M | 2.0M | |
| Change To Account Receivables | 4K | (35K) | 14K | (3.6M) | (3.2M) | (3.1M) | |
| End Period Cash Flow | 98.8M | 110.6M | 76.7M | 7.0M | 8.0M | 7.6M | |
| Stock Based Compensation | 3.0M | 3.3M | 2.3M | 568K | 511.2K | 485.6K | |
| Begin Period Cash Flow | 62.4M | 98.8M | 110.6M | 76.7M | 88.2M | 67.3M | |
| Issuance Of Capital Stock | 97.0M | 71.9M | 6.6M | 164K | 147.6K | 140.2K |
Pair Trading with Mustang Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Mustang Stock
| 0.65 | DNLI | Denali Therapeutics | PairCorr |
| 0.67 | EVOK | Evoke Pharma | PairCorr |
| 0.8 | FOLD | Amicus Therapeutics | PairCorr |
| 0.68 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Mustang Stock
| 0.56 | BMY | Bristol Myers Squibb | PairCorr |
| 0.54 | LFCR | Lifecore Biomedical | PairCorr |
| 0.4 | IMCC | Im Cannabis Corp | PairCorr |
| 0.33 | GILD | Gilead Sciences | PairCorr |
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.